Article Correctness Is Author's Responsibility: FDA Accepts NDA for Narcolepsy, OSA-Related Sleepiness Treatment

The article below may contain offensive and/or incorrect content.

The FDA has accepted the New Drug Application for solriamfetol for the treatment of sleep disorders.